These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19235166)

  • 1. Combined analysis of transcriptome and proteome data as a tool for the identification of candidate biomarkers in renal cell carcinoma.
    Seliger B; Dressler SP; Wang E; Kellner R; Recktenwald CV; Lottspeich F; Marincola FM; Baumgärtner M; Atkins D; Lichtenfels R
    Proteomics; 2009 Mar; 9(6):1567-81. PubMed ID: 19235166
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systematic comparative protein expression profiling of clear cell renal cell carcinoma: a pilot study based on the separation of tissue specimens by two-dimensional gel electrophoresis.
    Lichtenfels R; Dressler SP; Zobawa M; Recktenwald CV; Ackermann A; Atkins D; Kersten M; Hesse A; Puttkammer M; Lottspeich F; Seliger B
    Mol Cell Proteomics; 2009 Dec; 8(12):2827-42. PubMed ID: 19752005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of renal cell carcinoma-associated markers via proteome- and other 'ome'-based analyses.
    Seliger B; Lichtenfels R; Kellner R
    Brief Funct Genomic Proteomic; 2003 Oct; 2(3):194-212. PubMed ID: 15239923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptome-proteome integration of archival human renal cell carcinoma biopsies enables identification of molecular mechanisms.
    Koch E; Finne K; Eikrem Ø; Landolt L; Beisland C; Leh S; Delaleu N; Granly M; Vikse BE; Osman T; Scherer A; Marti HP
    Am J Physiol Renal Physiol; 2019 May; 316(5):F1053-F1067. PubMed ID: 30838877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro.
    Zieren RC; Dong L; Clark DJ; Kuczler MD; Horie K; Moreno LF; Lih TM; Schnaubelt M; Vermeulen L; Zhang H; de Reijke TM; Pienta KJ; Amend SR
    Med Oncol; 2021 Jul; 38(9):105. PubMed ID: 34331598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic biomarkers for renal cell carcinoma: selection using novel bioinformatics systems for microarray data analysis.
    Osunkoya AO; Yin-Goen Q; Phan JH; Moffitt RA; Stokes TH; Wang MD; Young AN
    Hum Pathol; 2009 Dec; 40(12):1671-8. PubMed ID: 19695674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative proteomic analysis in metastatic renal cell carcinoma reveals a unique set of proteins with potential prognostic significance.
    Masui O; White NM; DeSouza LV; Krakovska O; Matta A; Metias S; Khalil B; Romaschin AD; Honey RJ; Stewart R; Pace K; Bjarnason GA; Siu KW; Yousef GM
    Mol Cell Proteomics; 2013 Jan; 12(1):132-44. PubMed ID: 23082029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stage-related alterations in renal cell carcinoma--comprehensive quantitative analysis by 2D-DIGE and protein network analysis.
    Junker H; Venz S; Zimmermann U; Thiele A; Scharf C; Walther R
    PLoS One; 2011; 6(7):e21867. PubMed ID: 21760917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Panel of candidate biomarkers for renal cell carcinoma.
    Kim DS; Choi YP; Kang S; Gao MQ; Kim B; Park HR; Choi YD; Lim JB; Na HJ; Kim HK; Nam YP; Moon MH; Yun HR; Lee DH; Park WM; Cho NH
    J Proteome Res; 2010 Jul; 9(7):3710-9. PubMed ID: 20455597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of CXCL13 as a potential biomarker in clear cell renal cell carcinoma via comprehensive bioinformatics analysis.
    Xu T; Ruan H; Song Z; Cao Q; Wang K; Bao L; Liu D; Tong J; Yang H; Chen K; Zhang X
    Biomed Pharmacother; 2019 Oct; 118():109264. PubMed ID: 31390578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the dopamine transporter SLC6A3 as a biomarker for patients with renal cell carcinoma.
    Schrödter S; Braun M; Syring I; Klümper N; Deng M; Schmidt D; Perner S; Müller SC; Ellinger J
    Mol Cancer; 2016 Feb; 15():10. PubMed ID: 26831905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging the clear cell renal cell carcinoma proteome.
    Morgan TM; Seeley EH; Fadare O; Caprioli RM; Clark PE
    J Urol; 2013 Mar; 189(3):1097-103. PubMed ID: 23009866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microarray-based identification of CUB-domain containing protein 1 as a potential prognostic marker in conventional renal cell carcinoma.
    Awakura Y; Nakamura E; Takahashi T; Kotani H; Mikami Y; Kadowaki T; Myoumoto A; Akiyama H; Ito N; Kamoto T; Manabe T; Nobumasa H; Tsujimoto G; Ogawa O
    J Cancer Res Clin Oncol; 2008 Dec; 134(12):1363-9. PubMed ID: 18483744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma.
    Giribaldi G; Barbero G; Mandili G; Daniele L; Khadjavi A; Notarpietro A; Ulliers D; Prato M; Minero VG; Battaglia A; Allasia M; Bosio A; Sapino A; Gontero P; Frea B; Fontana D; Destefanis P
    J Proteomics; 2013 Oct; 91():385-92. PubMed ID: 23916412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential protein profiling of renal cell carcinoma urinary exosomes.
    Raimondo F; Morosi L; Corbetta S; Chinello C; Brambilla P; Della Mina P; Villa A; Albo G; Battaglia C; Bosari S; Magni F; Pitto M
    Mol Biosyst; 2013 Jun; 9(6):1220-33. PubMed ID: 23511837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linkage of microRNA and proteome-based profiling data sets: a perspective for the priorization of candidate biomarkers in renal cell carcinoma?
    Seliger B; Jasinski S; Dressler SP; Marincola FM; Recktenwald CV; Wang E; Lichtenfels R
    J Proteome Res; 2011 Jan; 10(1):191-9. PubMed ID: 21142213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteotranscriptomic Analysis Reveals Stage Specific Changes in the Molecular Landscape of Clear-Cell Renal Cell Carcinoma.
    Neely BA; Wilkins CE; Marlow LA; Malyarenko D; Kim Y; Ignatchenko A; Sasinowska H; Sasinowski M; Nyalwidhe JO; Kislinger T; Copland JA; Drake RR
    PLoS One; 2016; 11(4):e0154074. PubMed ID: 27128972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.